Induction of cellular and humoral immunity after aerosol or subcutaneous administration of Edmonston-Zagreb measles vaccine as a primary dose to 12-month-old children.
Induction of cellular and humoral immunity after aerosol or subcutaneous administration of Edmonston-Zagreb measles vaccine as a primary dose to 12-month-old children.
复制标题
对 12 个月大的儿童进行气雾剂或皮下注射埃德蒙斯顿-萨格勒布麻疹疫苗作为初级剂量后诱导细胞和体液免疫。
DOI:
10.1086/380565
复制
发表时间:
2004
期刊:
影响因子:
--
通讯作者:
Valdespino-Gómez,JoséLuis
中科院分区:
文献类型:
--
作者:
Wong-Chew,RosaMaría;Islas-Romero,Rocío;García-García,MariadeLourdes;Beeler,JudyA;Audet,Susette;Santos-Preciado,JoseIgnacio;Gans,Hayley;Lew-Yasukawa,Linda;Maldonado,YvonneA;Arvin,AnnM;Valdespino-Gómez,JoséLuis
Infants were immunized by aerosol (103.6plaque-forming units [pfu]/dose) or subcutaneous (sc) (104.27pfu/dose) administration of Edmonston-Zagreb measles vaccine. Measles-specific T cell proliferative responses with a stimulation index of ⩾3 developed in 72% of children given aerosol-administered vaccine, compared with 87% given sc-administered vaccine (P= .06). Seroconversion rates were 90% after aerosol-administered vaccine and 100% after sc-administered vaccine (P=.01), and measles geometric mean titers were 237 milli–international units (mIU) (95% confidence interval [CI], 146–385 mIU) and 487 mIU (95% CI, 390–609 mIU) in each group, respectively (P=.01). Measles-specific T and B cell responses were weaker after aerosol than after sc vaccination, indicating a need to use a higher aerosol dose to achieve optimal immunogenicity